Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc. T.MBX

Alternate Symbol(s):  MBXBF

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.


TSX:MBX - Post by User

Post by RazeKreationson Dec 04, 2020 6:24pm
252 Views
Post# 32042496

QAP's and related products

QAP's and related productsMicrobix currently has 66 different QAP products. 19 are Covid related 47 for various other conditions.  even when Covid gets under control ther will still need to be testing for it just like the annual flu bug. When the pandemic is under control all the other products will be more in demand as doctors and labs have more time and resources for those tests.  Back in June 27th 2007 Kinlytic was the big story and it drove MBX share price up to 1.60 and that was based purely on speculation. What is happening now is NOT speculative but real actual sales and production.  And then there is VTM wich is just exploding in demand and MBX has the credentials,ability and sales now.  The US market is estimated at 2.2 Billion dollars for VTM annualy and growing. Canada Market probably 10% of that. Then on top of that MBX has 30 different antigens products.  Start adding all that up and then you will realize that the current share price is dirt cheap. What is happening now far surpasses anything Kinlytic would do when you add it all together. 
VTM..........QAP's.............Antigens..........
<< Previous
Bullboard Posts
Next >>